Patent Number: 7,820,686

Title: Therapeutic agent for inflammatory bowel disease

Abstract: The invention is directed to a method of treating an inflammatory bowel disease such as ulcerative colitis or Crohn's disease, which comprises administering an effective amount of the therapeutic agent 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione, or a pharmaceutically acceptable salt thereof, to a patient with inflammatory bowel disease.

Inventors: Takebayashi; Yuji (Fukushima, JP)

Assignee: Taiho Pharmaceutical Co., Ltd.

International Classification: A61K 31/506 (20060101)

Expiration Date: 2018-10-26 0:00:00